Rosiglitazone Alleviates Contrast-Induced Acute Kidney Injury in Rats via the PPAR < em > γ < /em > /NLRP3 Signaling Pathway

CONCLUSION: Rosiglitazone could alleviate acute renal injury in the CI-AKI rat model by regulating the PPARγ/NLRP3 signaling pathway and should be further investigated as a potential treatment in clinical studies.PMID:36225198 | PMC:PMC9550500 | DOI:10.1155/2022/4158692

Source: Disease Markers - October 13, 2022 Category: Laboratory Medicine Authors: Jiayi Wu Jinhua Huang En Chen Xingchun Zheng Source Type: research